col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

85 Results       Page 1

Elsevier: Atherosclerosis
  original article Date Title Authors   All Authors
1 [GO] 2023―Aug―29 Endothelial function and arterial stiffness of patients with cardiovascular diseases hospitalized due to COVID-19 C. Araújo, A. Dornelas De Andrade, J. Fernandes, D. Caetano, A.E. Barros, J. Souza, et al. (+5)
2 [GO] 2023―Aug―29 Endothelial functional status in patients with atherosclerotic coronary artery disease and type 2 diabetes mellitus after COVID-19 S. Ubaydullaev, A. Alyavi, J. Uzokov
3 [GO] 2023―Aug―29 Indicators of myocardial electrical instability during high-dose atorvastatin therapy in patients after acute myocardial infarction in combination with COVID-19 V. Oleynikov, Y. Barmenkova, A. Tonkoglaz, M. Lukyanova, I. Avdeeva
4 [GO] 2023―Aug―29 The impact of statin therapy on in-hospital prognosis and endothelial function of patients at high-to-very high cardiovascular risk admitted for COVID-19 V. Bianconi, M. Mannarino, E. Cosentini, F. Figorilli, C. Colangelo, G. Cellini, et al. (+4)
5 [GO] 2023―Aug―29 Intracardiac hemodynamics and heart rate variability in stable coronary artery disease patients with concomitant COVID-19 V. Netiazhenko, S. Mostovyi, O. Safonova, K. Mikhaliev
6 [GO] 2023―Aug―29 Thromboinflammation prevention in COVID-19 hospitalised patients: A retrospective study G. Chatzis, M. Vlachopoulou, K. Koronios, E. Stratigaki, D. Fellouri, G. Aleiferis, et al. (+4)
7 [GO] 2023―Aug―29 Effect of polypill therapy on lipid profile and arterial stiffness in patients with dyslipidemia, arterial hypertension and COVID-19 in different age groups V. Oleynikov, L. Salyamova, K. Pavlenko, M. Lukyanova, N. Borisova
8 [GO] 2023―Aug―29 Low high-density lipoprotein level is a risk factor for postvaccination COVID-19 in hemodialysis patients N. Stepanova, A. Rysyev, L. Snisar
9 [GO] 2023―Aug―29 Cardiovascular disease (CVD) and COVID-19 infection: A deadly synergism J. Hamilton, N. Huang, M. Saeed, M. Sagar, A. Zheng
10 [GO] 2023―Aug―29 Effects of COVID-19 severity on the atherosclerotic risk POS-recovery: Relation between inflammation and lipoproteins R. Conde, R. Gil-Redondo, M. Bizkarguenaga, C. Bruzzone, A. Laín, B. González-Valle, et al. (+5)
11 [GO] 2023―Aug―29 Characteristics of acute coronary syndrome during COVID 19 pandemic L. Ferhatbegovic, B. Pojskic
12 [GO] 2022―Aug―30 Cardiovascular outcomes of COVID-19 disease at the elderly A. Capisizu, R. Mihalache, A. Capisizu, M. Roman, S.M. Aurelian
13 [GO] 2022―Aug―30 Thromboembolic complications in COVID-19 clinical case A. Capisizu, S.A. Capisizu, D. Cuzino, A. Zamfirescu
14 [GO] 2022―Aug―30 Association of self-reported health and wellbeing indicators with a positive diagnosis for COVID-19. CARTSESIAN-CY study G. Photiou, N. Middleton, D.B. Panagiotakos, A. Panayiotou
15 [GO] 2022―Aug―30 Characteristic of patients with COVID-19 and myocardial infarction N.A. Koriagina, V.S. Koriagin, K.V. Prokhorov, G.N. Spasenkov
16 [GO] 2022―Aug―30 Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence A.G. L'Huillier, S. Pagano, S. Baggio, B. Meyer, D.O. Andrey, M. Nehme, et al. (+8)
17 [GO] 2022―Aug―30 COVID-19 and cardiovascular system: Not only heart but also vascular. The effects of the infection on arterial stiffness A. Maloberti, E. Gualini, S. Scarpellini, M. Algeri, M. Biolcati, E. Grasso, et al. (+3)
18 [GO] 2022―Aug―30 Coronary artery disease is an independent risk factor for in-hospital COVID-19 all-cause mortality A.V. Shalaeva, K.T. Mirakhmedova, N.A. Dadabaeva, S.S. Egamova, U.S. Abdullaev, A.K. Shadmanov
19 [GO] 2022―Aug―30 Flow-mediated dilation of the brachial artery in patients with obesity after COVID-19 O. Pogorelova, I.O. Kokaeva, M. Tripoten, Y. Zhernakova, T. Balakhonova
20 [GO] 2022―Aug―30 Apolipoproteins A1 level in the plasma of patients with COVID-19 L.K. Sokolova, J.B. Belchina, V.M. Pushkarev, O.I. Kovzun, V.V. Pushkarev, M.D. Tronko
21 [GO] 2022―Aug―30 Cardiovascular risk factors in patients with primary myocardial infarction in combination with COVID-19 V. Oleynikov, L. Salyamova, K. Korenkova, K. Polezhaeva, N. Donetskaya, A. Babina
22 [GO] 2022―Aug―30 Features of indicators of central pressure and stiffness in patients with primary myocardial infarction in combination with COVID-19 V. Oleynikov, L. Salyamova, M. Lukyanova, K. Korenkova, A. Kulyutsin
23 [GO] 2022―Aug―30 The possible role of TyG index and TRG/HDL, CRP/HDL, NEUTROPHILS/HDL lymphocytes/HDL ratios in disease severity and outcomes in COVID-19 hospitalized patients with arterial hypertension A. Liontos, D. Biros, A. Papathanasiou, O. Milionis, M. Nasiou, E. Pargana, et al. (+15)
24 [GO] 2022―Aug―30 FT-IR spectroscopic study of atheromatic plaque formation and the risk of COVID-19 mortality of patients with cardiovascular diseases. A mathematical simulation approach I. Mamarelis, J. Anastassopoulou, E. Mylonas, V. Mamareli, K. Spiliopoulos, T. Theophanides
25 [GO] 2022―Aug―30 Impact of COVID-19 outbreak in stemi patients in the regional emergency center in Seoul, Korea Y. Cho, Y. Yoon, S. Park
26 [GO] 2022―Aug―30 Adaptation of a new cardiac rehabilitation program in times of COVID-19 pandemic M. A. Martin Toro, M. S. Herruzo Rojas, E. J. Martinez De Morentin Laurenz, S. Blasco Turrion, F. J. Morales Ponce
27 [GO] 2022―Aug―30 Medical care to patients with acute myocardial infarction during COVID-19 pandemic N.A. Koriagina, V.S. Koriagin, K.V. Prokhorov, G.N. Spasenkov
28 [GO] 2022―Aug―30 Acute coronary syndrome outside and during the COVID-19 pandemic N.A. Koriagina, V.S. Koriagin, A.I. Maltcev, S.G. Shulkina
29 [GO] 2022―Aug―30 The management of patients with chronic cardiovascular therapies in Lombardy region: The impact of the COVID-19 pandemic F. Galimberti, E. Olmastroni, A.L. Catapano, E. Tragni, M. Casula
30 [GO] 2022―Aug―30 New semi-presential modality in cardiac rehabilitation due to COVID-19 pandemic. What results have we obtained? M. A. Martin Toro, M. S. Herruzo Rojas, E. J. Martinez De Morentin Laurenz, S. Blasco Turrion, F. J. Morales Ponce
31 [GO] 2022―Aug―30 Risk factors of deep vein thrombosis in COVID-19 patients M. Tripoten, O. Pogorelova, T. Balakhonova
32 [GO] 2022―Aug―30 Uncontrolled vs controlled type 2 diabetes and increased risk of 30-days all-cause mortality in COVID-19 patients E.V. Shalaeva, M.I. Shamsutdinova, F.L. Azizova, O.R. Teshaev, S.A. Boymuradov, H. Saner
33 [GO] 2022―Aug―30 Significance of LDL-C in appearance of myocardial infarction in COVID-19 patients in Bosnian population - One center experience L. (Pojskic) Ferhatbegovic, B. Pojskic, D. Mrsic
34 [GO] 2022―Aug―30 Laboratory findings and clinical outcomes of 681 COVID-19 patients with dyslipidemia requiring hospitalization A. Liontos, D. Biros, O. Milionis, S. Tsourlos, L. Athanasiou, A. Papathanasiou, et al. (+20)
35 [GO] 2022―Aug―30 Thrombotic and thromboembolic events in COVID-19 patients: Association with clinical presentation, progression and laboratory findings. Data analysis of a 681 patient cohort A. Liontos, D. Biros, S. Tsourlos, L. Athanasiou, O. Milionis, A. Papathanasiou, et al. (+23)
36 [GO] 2022―Aug―30 Baseline high-density lipoprotein level is associated with COVID-19 pneumonia severity in hemodialysis patients N. Stepanova, A. Rysyev, O. Rusyn, T. Ostapenko, L. Snisar, S. Rusanov
37 [GO] 2022―Aug―30 Modifiable and non-modifiable cardiovascular risk factors on sensory disorder of smell and taste in COVID-19 population A. Liontos, A. Zarachi, O. Milionis, P. Vasileios, I. Komnos, E. Klouras, et al. (+6)
38 [GO] 2022―Aug―30 Association of cardiovascular risk factors and olfactory or taste dysfunction in COVID-19 population. Data from an academic center in Greece A. Liontos, A. Zarachi, O. Milionis, P. Vasileios, I. Komnos, A. Lianou, et al. (+6)
39 [GO] 2022―Aug―30 Coronary atherosclerosis in COVID-19 survivors: Association with cardiac injury and function at 6 weeks R.A. Groen, M.A. De Graaf, W.J. Jukema, M.J. Schalij, J.L. Stöger, J.J.M. Geelhoed, M.L. Antoni
40 [GO] 2022―Aug―30 COVID-19 vaccination associated severe immune thrombocytopenia: A case report M. Mousdi, S. Pegka, M. Skouteli, K. Trachana, G. Chatzis, S. Bakidis
41 [GO] 2022―Aug―30 Relationship between biomarkers and global myocardial strain parameters in patients with cardiovascular pathology and metabolic disorders after COVID-19-associated pneumonia T. Petelina, N. Musikhina, E. Yaroslavskaya, E. Gorbatenko, N. Galeeva, K. Avdeeva, et al. (+2)
42 [GO] 2022―Aug―30 Coronavirus at the heart center of Puerto Rico incidence-death: The role of genetics C.M. Diaz, L.E. Barreto, P.I. Altieri, H.L. Banchs, N. Villar, F.J. Colón
43 [GO] 2022―Aug―30 Maternal fructose intake reinforces the effects of a Western-type diet in promoting SARS-CoV-2 cell entry factors in male offspring C. Donis, E. Fauste, M. Pérez, L. Rodríguez, S. Rodrigo, J.J. Álvarez-Millán, et al. (+3)
44 [GO] 2022―Aug―30 Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality A. Maloberti, C. Giannattasio, P. Rebora, G. Occhino, N. Ughi, J. Rizzo, et al. (+11)
45 [GO] 2022―Aug―30 Lipoprotein(a) and SARS-CoV-2 infections: Risk for ischemic heart disease and thromboembolic events S. Di Maio, C. Lamina, S. Coassin, L. Forer, R. Würzner, S. Schönherr, F. Kronenberg
46 [GO] 2022―Aug―30 Direct and indirect effects of SARS-CoV-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation R. Scicali, V. Ferrara, S. Piro, F. Purrello, A. Di Pino
47 [GO] 2022―Aug―30 A mouse model of arterial endothelial cell-specific inflammation reveals pathways of endothelial dysfunction and the simultaneous upregulation of ACE2, the receptor of SARS-CoV2 J.A. Schmid, M. Mussbacher, J. Basílio, M. Salzmann
48 [GO] 2022―Aug―02 Lipoprotein(a) during COVID-19 hospitalization: Thrombosis, inflammation, and mortality Morten Kaltoft, Kathrine Glavind, Sune Fallgaard Nielsen, Anne Langsted, Kasper Karmark Iversen, Børge Grønne Nordestgaard, Pia Rørbæk Kamstrup
49 [GO] 2022―Mar―12 Lipoprotein(a) in COVID-19: Genetics and inflammation collide Martina Montagnana, Giuseppe Lippi
50 [GO] 2021―Dec―22 Pre-infection HDL-cholesterol levels and mortality among elderly patients infected with SARS-CoV-2 Jose M. Mostaza, Miguel A. Salinero-Fort, Juan Cardenas-Valladolid, Fernando Rodriguez-Artalejo, Mariana Díaz-Almiron, Pilar Vich-Pérez, et al. (+3)
51 [GO] 2021―Dec―21 Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study Nick S. Nurmohamed, Didier Collard, Laurens F. Reeskamp, Yannick Kaiser, Jeffrey Kroon, Tycho R. Tromp, et al. (+9)
52 [GO] 2021―Nov―13 Fenofibrate as a COVID-19 modifying drug: Laboratory success versus real-world reality Michael Feher, Mark Joy, Neil Munro, William Hinton, John Williams, Simon de Lusignan
53 [GO] 2021―Sep―15 Reply to: “Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead” Monica Verdoia, Giuseppe De Luca
54 [GO] 2021―Sep―03 Dynamic of lipoprotein responses in patients with severe COVID-19 A. Leonard, A. Doolan, G. Boran, D. Burke, T. Moulton, M. Donnelly, et al. (+2)
55 [GO] 2021―Sep―03 Hepatic transcriptional effects of simvastatin and the possible impact on COVID-19 O. Ahmed, A.K. Mukarram, C. Pirazzini, E. Elena Marasco, M. Pedrelli, M.E. Minniti, et al. (+8)
56 [GO] 2021―Sep―03 Patients with symptomatic coronary artery disease are at the increased risk of worsening the course of the disease after recovery from COVID-19 A.V. Shalaeva, K.T. Mirakhmedova, A.K. Shadmanov
57 [GO] 2021―Sep―03 SARS-COV-2 (COVID-19) anosmia in patients with obesity: A retrospective study N. Sarantis, M. Vlachopoulou, G. Chatzis
58 [GO] 2021―Sep―03 Retrospective study of patients admitted form March to January 2021 by COVID-19 in hospital Infanta Elena (Huelva). M.E. Mansilla Rodríguez, A. Fulgencio Delgado, G. Mariscal Vázquez, J.I. Ramos Clemente Romero
59 [GO] 2021―Sep―03 presentation of SARS-CoV-2 (COVID-19 in patients with congestive heart failure. A Retrospective study G. Chatzis, M. Vlachopoulou, A.E. Gawish, A.A.A. Alslmy, M.A. Karish, N.K. Aljarbaa, et al. (+10)
60 [GO] 2021―Sep―03 Can plasma lipid levels be correlated to severe COVID-19 infection? O.A. Uyaroğlu, M. Özdede, N. Çalık Başaran, B. Köylü, T.K. Şahin, L. Özışık, et al. (+2)
61 [GO] 2021―Sep―03 COVID-19 pandemic and triggered acute myocardial infarction and out-of-hospital cardiac arrest in non-infected individuals A. Hammoudeh, E. Mdanat, R. Almoheisen, M. Jabari, H. Janabi, R. Ibdah
62 [GO] 2021―Sep―03 How the way we live will look different in the wake of the COVID-19 pandemic? A survey in Greece D.B. Panagiotakos, R. Kosti, C. Vassou, C. Pitsavos
63 [GO] 2021―Sep―03 COVID-19-related quarantine effect on dietary habits in a northern italian rural population: Data from the BRISIGHELLA heart study A.F.G. Cicero, F. Fogacci, M. Giovannini, M. Mezzadri, E. Grandi, C. Borghi
64 [GO] 2021―Sep―03 Statin therapy and COVID-19: A retrospective cohort study in a province of Northern Italy S. Greco, F. Luciani, E. Giorgini, A. D'Amuri, M. Lopreiato, V. Fortunato, et al. (+4)
65 [GO] 2021―Sep―03 Diabetes and overweight/obesity are independent, non-additive, risk factors for the in-hospital severity of COVID-19: An international, multi-center retrospective analysis D.K. Longmore, J.E. Miller, S. Bekkering, C. Saner, E. Mifsud, Y. Zhu, et al. (+5)
66 [GO] 2021―Sep―03 Cholesterol and COVID-19: Findings from lipid profile of patients with SARS-COV-2 infection. I. Rossi, D. D'Ardes, B. Bucciarelli, M. Allegra, M.T. Guagnano, F. Santilli, et al. (+5)
67 [GO] 2021―Sep―03 Development features of coronavirus disease complications in patients with coronary heart disease N.M. Nurillaeva, M.M. Makhkamova, K.B. Omarov
68 [GO] 2021―Sep―03 Creation of a transgenic mouse model to study the SARS-CoV-2 effect on the pathogenesis of atherosclerosis M. Kubekina, L. Ilchuk, A. Bruter, A. Deykin
69 [GO] 2021―Sep―03 Acute myocardial infarction after laboratory confirmed SARS-CoV-2 infection J. Ena, M. Bou-Collado, M.D. Reyes-Jara, R. Afonso-Carrillo, R. Mulet, V. Valls
70 [GO] 2021―Sep―03 SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1 S. Pagano, S. Yery, B. Meyer, C. Juillard, N. Suh, C. Le Terrier, et al. (+15)
71 [GO] 2021―Sep―03 How controlled were dyslipidemias in a year of pandemic? E.M.M. Silva, B. Marques, C. Cunha, R. Ferreira, C. Bello, C. Limbert, et al. (+2)
72 [GO] 2021―Aug―12 Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead Marco Zuin, Gianluca Rigatelli, Giovanni Zuliani, Loris Roncon
73 [GO] 2021―Jul―21 Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry Giuseppe De Luca, Niels Debel, Miha Cercek, Lisette Okkels Jensen, Marija Vavlukis, Lucian Calmac, et al. (+75)
74 [GO] 2021―Jun―25 Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis Anastasios Kollias, Konstantinos G. Kyriakoulis, Ioannis G. Kyriakoulis, Thomas Nitsotolis, Garyphallia Poulakou, George S. Stergiou, Konstantinos Syrigos
75 [GO] 2021―May―27 Teaching an old dog new tricks: The prognostic role of CACS in hospitalized COVID-19 patients Ahmed Ibrahim Ahmed, Paolo Raggi, Mouaz H. Al-Mallah
76 [GO] 2021―Apr―17 The prognostic role of cardiac troponin in hospitalized COVID-19 patients Ibrahim Halil Tanboğa, Uğur Canpolat, Elif Hande Özcan Çetin, Harun Kundi, Sema Turan, Osman Celik, et al. (+5)
77 [GO] 2021―Apr―07 Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19 Alessandra Scoccia, Guglielmo Gallone, Alberto Cereda, Anna Palmisano, Davide Vignale, Riccardo Leone, et al. (+32)
78 [GO] 2021―Feb―15 Coronavirus disease-19: The multi-level, multi-faceted vasculopathy Thiago Quinaglia, Mahsima Shabani, Ikaro Breder, Harry A. Silber, João A.C. Lima, Andrei C. Sposito
79 [GO] 2021―Jan―24 Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatment Alpo Vuorio, Frederick Raal, Markku Kaste, Petri T. Kovanen
80 [GO] 2020―Dec―23 Patient referrals audit: Evaluation of local cardiovascular risk clinic referrals to help aid patient triage during COVID-19 A.H. Boal, C.M. Ross
81 [GO] 2020―Dec―23 Obesity is a major risk factor for severe COVID-19 illness H.L. Li, B.M. Cheung
82 [GO] 2020―Oct―14 Endothelial dysfunction in COVID-19: Current findings and therapeutic implications Matthias P. Nägele, Bernhard Haubner, Felix C. Tanner, Frank Ruschitzka, Andreas J. Flammer
83 [GO] 2020―Sep―15 Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK Zohaib Iqbal, Jan Hoong Ho, Safwaan Adam, Michael France, Akheel Syed, Dermot Neely, et al. (+15)
84 [GO] 2020―Jun―16 Management of acute myocardial injury in patients with confirmed or suspected COVID-19 Yiannis S. Chatzizisis, Ganesh Gajanan, Deepak L. Bhatt, George Dangas, Thomas Porter
85 [GO] 2020―May―28 SARS-CoV-2 as a protective factor for cardiovascular mortality? Frédéric Dutheil, Marion Trousselard, Valentin Navel

85 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec